State Street’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,800
Closed -$1.77K 4340
2025
Q1
$1.77K Hold
32,800
﹤0.01% 4279
2024
Q4
$18.1K Hold
32,800
﹤0.01% 4242
2024
Q3
$32.1K Hold
32,800
﹤0.01% 4165
2024
Q2
$40K Sell
32,800
-103,507
-76% -$177K ﹤0.01% 4185
2024
Q1
$516K Hold
136,307
﹤0.01% 3640
2023
Q4
$90K Sell
136,307
-3,547
-3% -$4.87K ﹤0.01% 4071
2023
Q3
$545K Buy
139,854
+16,950
+14% +$77.9K ﹤0.01% 3647
2023
Q2
$739K Buy
+122,904
New +$720K ﹤0.01% 3620

Other funds holding OCEA

State Street's OCEA Position: Q2 2025 in Review

State Street sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 32,800 shares — an estimated $1.77K sold.

State Street first reported a position in OCEA in Q2 2023 and held it in 8 quarters. The position peaked at $739K in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • State Street reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • State Street sold 32,800 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $1.77K.
  • State Street first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 8 quarters.
  • State Street's Ocean Biomedical, Inc. Common Stock position peaked at $739K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.